340B issues and patient access to pharmaceuticals. Coronavirus response efforts, including related provisions in: (1) H.R. 6074, the Coronavirus Preparedness and Response Supplemental Appropriations Act; (2) H.R. 6201, the Families First Coronavirus Response Act; and (3) H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act. Implementation issues affecting patient access to Medicare covered pharmaceuticals and reimbursement adequacy, including related provisions modifying Medicare Parts B and D benefit parameters, coverage, and reimbursement requirements in H.R. 3, the Lower Drug Costs Now Act and S. 2543, the Prescription Drug Pricing Reduction Act; use of step therapy in Medicare and health insurance coverage; and legislative efforts to modify the Center for Medicare & Medicaid Innovation to preserve patient access to medically-necessary treatments. Coronavirus response efforts, including related provisions in: (1) H.R. 6074, the Coronavirus Preparedness and Response Supplemental Appropriations Act; (2) H.R. 6201, the Families First Coronavirus Response Act; and (3) H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including related provisions in H.R. 5741, the Strengthening Innovation in Medicare and Medicaid Act.
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
CAPITOL COUNSEL LLC
700 13th Street NW, 2nd Floor, Washington, DC, 20005, US
DENISE HENRY MORRISEY SHANNON FINLEY SARA FRANKO LUKE HATZIS MARTIN B. GOLD ANN JABLON AARON COHEN CAITLIN CANTER DENISE HENRY MORRISEY SHANNON FINLEY SARA FRANKO LUKE HATZIS MARTIN B. GOLD ANN JABLON AARON COHEN CAITLIN CANTER